Label Changes for:

Plasma-Lyte 148 and Plasma-Lyte A pH 7.4 (Multiple Electrolytes, Type 1, USP) Injection

September 2013

Changes have been made to the CONTRAINDICATIONS, WARNINGS, PRECAUTIONS and ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

September 2013

CONTRAINDICATIONS

WARNINGS

PRECAUTIONS

ADVERSE REACTIONS

Note: all four sections above extensively rewritten. See PI for details.

Hide
(web1)